Zydus Cadila Gets Usfda Approval To Market Generic Version Of Deferasirox Tablets

Zydus Cadila Gets Usfda Approval To Market Generic Version Of Deferasirox Tablets

By, Admin 18 June 2020

Zydus Cadila, Part Of Cadila Healthcare Group, On Tuesday Said It Has Received Final Approval From The Us Health Regulator To Market Its Generic Version Of Deferasirox Tablets Used In Treatment Of Chronic Iron Overload Due To Blood Transfusions. The Approval By The Us Food And Drug Administration (Usfda) For Deferasirox Tablets Is For Multiple Strengths Of 90 Mg, 180 Mg And 360 Mg, Cadila Healthcare Said In A Regulatory Filing.Deferasirox Binds To Iron And Removes It From The Bloodstream. It Is Used To Treat Iron Overload Caused By Blood Transfusions In Adults And Children Who Are At Least Two Years Old.It Is Also Used To Treat Chronic Iron Overload Syndrome Caused By A Genetic Blood Disorder (Non-Transfusion Dependent Thalassemia) In Adults And Children Who Are At Least 10 Years Old, The Company Said."The Drug Will Be Manufactured At The Group'S Manufacturing Facility At Special Economic Zone, Ahmedabad," It Added. The Group Now Has 291 Approvals And Has So Far Filed Over 390 Abbreviated New Drug Applications Since The Commencement Of The Filing Process In Fy 2003-04.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!